• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient.

作者信息

Mattei D, Feola M, Orzan F, Mordini N, Rapezzi D, Gallamini A

出版信息

Bone Marrow Transplant. 2009 Jun;43(12):967-8. doi: 10.1038/bmt.2008.415. Epub 2008 Dec 22.

DOI:10.1038/bmt.2008.415
PMID:19104491
Abstract
摘要

相似文献

1
Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient.在一名既往接受过同种异体移植的慢性粒细胞白血病患者中，达沙替尼诱发可逆性肺动脉高压和右心室衰竭。
Bone Marrow Transplant. 2009 Jun;43(12):967-8. doi: 10.1038/bmt.2008.415. Epub 2008 Dec 22.
2
Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia.与达沙替尼治疗慢性粒细胞白血病相关的完全可逆性肺动脉高压。
Eur Respir J. 2011 Jul;38(1):218-20. doi: 10.1183/09031936.00154210.
3
Use of β-Blockers in Pulmonary Hypertension.β受体阻滞剂在肺动脉高压中的应用。
Circ Heart Fail. 2017 Apr;10(4). doi: 10.1161/CIRCHEARTFAILURE.116.003703.
4
[Reversible pulmonary arterial hypertension related to dasatinib in the treatment for chronic myelogenous leukemia: a case report and literature review].[达沙替尼治疗慢性粒细胞白血病相关的可逆性肺动脉高压：一例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2014 Jul;35(7):581-6. doi: 10.3760/cma.j.issn.0253-2727.2014.07.002.
5
[Diagnosis and treatment of right ventricular dysfunction].[右心室功能障碍的诊断与治疗]
Dtsch Med Wochenschr. 2011 Jun;136(22):1184-6. doi: 10.1055/s-0031-1280536. Epub 2011 May 24.
6
Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia.可逆性肺动脉高压可能与长期低剂量达沙替尼治疗慢性髓性白血病有关。
Leuk Res. 2012 Jan;36(1):e4-6. doi: 10.1016/j.leukres.2011.08.007. Epub 2011 Sep 3.
7
New insights for the diagnosis and management of right ventricular failure, from molecular imaging to targeted right ventricular therapy.从分子成像到靶向右心室治疗：右心室衰竭诊断和管理的新见解。
Curr Opin Cardiol. 2010 Mar;25(2):131-40. doi: 10.1097/HCO.0b013e328335febd.
8
Management of right heart failure in the critically ill.危重症患者右心衰竭的管理
Crit Care Clin. 2014 Jul;30(3):475-98. doi: 10.1016/j.ccc.2014.03.003.
9
[Acute hemodynamic effects of intravenous administration of molsidomine in secondary pulmonary hypertension and right heart failure].[静脉注射吗多明对继发性肺动脉高压和右心衰竭的急性血流动力学影响]
Med Klin (Munich). 1994 Jul;89 Suppl 2:58-61.
10
The right ventricle in pulmonary hypertension.
Coron Artery Dis. 2005 Feb;16(1):13-8. doi: 10.1097/00019501-200502000-00003.

引用本文的文献

1
Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies.达沙替尼治疗慢性髓性白血病后的不良反应：特征、潜在机制及临床管理策略
Front Oncol. 2023 Feb 6;13:1113462. doi: 10.3389/fonc.2023.1113462. eCollection 2023.
2
Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia.慢性粒细胞白血病中酪氨酸激酶抑制剂的不良事件及剂量调整
Front Oncol. 2022 Oct 6;12:1021662. doi: 10.3389/fonc.2022.1021662. eCollection 2022.
3
Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy.
接受酪氨酸激酶抑制剂治疗的慢性髓性白血病患者的心血管不良事件及缓解策略
J Adv Pract Oncol. 2022 Mar;13(2):127-142. doi: 10.6004/jadpro.2022.13.2.4. Epub 2022 Mar 25.
4
Comparison of Dasatinib- and Imatinib-Related Cardiotoxic Adverse Events in Japanese Patients With Chronic Myeloid Leukemia and Gastrointestinal Stromal Tumor.日本慢性髓性白血病和胃肠道间质瘤患者中达沙替尼与伊马替尼相关心脏毒性不良事件的比较
Circ Rep. 2021 Nov 16;4(1):1-8. doi: 10.1253/circrep.CR-21-0140. eCollection 2022 Jan 7.
5
Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: A narrative review.2019冠状病毒病及其他病毒感染与间质性肺疾病、肺纤维化和肺动脉高压的关联：一项叙述性综述
Can J Respir Ther. 2020 Nov 26;56:1-9. doi: 10.29390/cjrt-2020-021. eCollection 2020.
6
Emerging antenatal therapies for congenital diaphragmatic hernia-induced pulmonary hypertension in preclinical models.先天性膈疝性肺动脉高压的产前治疗新进展：临床前模型研究。
Pediatr Res. 2021 May;89(7):1641-1649. doi: 10.1038/s41390-020-01191-x. Epub 2020 Oct 10.
7
EXPRESS: Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors.快报：达沙替尼及其他酪氨酸激酶抑制剂所致肺动脉高压
Pulm Circ. 2019 Jul 5;9(3):2045894019865704. doi: 10.1177/2045894019865704.
8
Myeloid-Derived Suppressor Cells and Pulmonary Hypertension.髓系来源抑制细胞与肺动脉高压。
Int J Mol Sci. 2018 Aug 3;19(8):2277. doi: 10.3390/ijms19082277.
9
Dasatinib-induced pulmonary arterial hypertension.达沙替尼致肺动脉高压。
Br J Clin Pharmacol. 2018 May;84(5):835-845. doi: 10.1111/bcp.13508. Epub 2018 Mar 6.
10
Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapy.慢性髓性白血病（CML）患者在酪氨酸激酶抑制剂（TKI）治疗下的心血管护理。
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):110-114. doi: 10.1182/asheducation-2017.1.110.